Cumberland Pharmaceuticals, the Nashville-based company that IPO'd 16 months ago, today announced an adverse FDA response to its requested sNDA. CP says it plans to seek a meeting. The news follows discord among some of the stock's analysts.
Cumberland Pharmaceuticals, the Nashville-based company that IPO'd 16 months ago, today announced an adverse FDA response to its requested sNDA. CP says it plans to seek a meeting. The news follows discord among some of the stock's analysts.
No comments:
Post a Comment